Literature DB >> 3262931

Immediate endoscopic sclerosis of bleeding esophageal varices. A prospective evaluation over five years.

K J Paquet1, J F Kalk, P Koussouris.   

Abstract

From January 1982 to January 1987, a prospective, nonrandomized sclerotherapy study was conducted at the Heinz-Kalk Hospital, Bad Kissingen, with 232 consecutive patients receiving immediate endoscopic injection sclerosis (IEIS) for variceal bleeding during emergency endoscopy. No patient was excluded from this study. All patients were classified according to the Child-Pugh criteria: 53 (23%) were in category A; 70 (30%) in category B; and 109 (47%) in category C. More than 93% had liver cirrhosis, 60% of alcoholic origin. IEIS was performed during emergency fiberoptic endoscopy applying 5-40 1-ml injections of 0.5% polidocanol by the paravariceal, "free" injection technique. If this was not successful, an intravariceal approach was used, and after 15 min of injection and persisting hemorrhage a Linton-Nachlas tube was inserted for 6-12 h. If hemorrhaging recurred, a second emergency endoscopy with IEIS was performed and, if this was not successful, a gastroesophageal disconnection followed directly. During the bleeding-free interval, Child-Pugh A and B patients were selected, using special criteria, for a shunt operation. An elective, semiselective, or selective shunt was recommended and carried out. In 56 patients (24%), a gastroesophageal disconnection or a shunt operation was performed on an emergency or elective basis. All sclerotherapy patients were controlled after 4 months and thereafter every 6, 9, or 12 months and reinjected if necessary. Bleeding was controlled in 93% of the cases with IEIS, and, in 97%, with a combination of IEIS and Linton-Nachlas tube. Definitive control of hemorrhaging was accomplished in 94% of the patients. Thirty-five patients died during the first 30 days of admission (15.1%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262931     DOI: 10.1007/bf00591393

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  19 in total

1.  GASTROESOPHAGEAL DECONGESTION AND SPLENECTOMY. A METHOD OF PREVENTION AND TREATMENT OF BLEEDING FROM ESOPHAGEAL VARICES ASSOCIATED WITH BILHARZIAL HEPATIC FIBROSIS: PRELIMINARY REPORT.

Authors:  M A HASSAB
Journal:  J Int Coll Surg       Date:  1964-03

2.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

3.  Endoscopic sclerotherapy of oesophageal varices. A clinical study.

Authors:  C Söderlund
Journal:  Acta Chir Scand Suppl       Date:  1985

4.  Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.

Authors:  B R MacDougall; D Westaby; A Theodossi; J L Dawson; R Williams
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

5.  Emergency endoscopic sclerotherapy for bleeding esophageal varices: a prospective study in patients not responding to balloon tamponade.

Authors:  W E Fleig; E F Stange; K Ruettenauer; H Ditschuneit
Journal:  Gastrointest Endosc       Date:  1983-02       Impact factor: 9.427

6.  Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial.

Authors:  J Terblanche; P C Bornman; D Kahn; M A Jonker; J A Campbell; J Wright; R Kirsch
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

7.  A comparison of immediate versus delayed endoscopic injection sclerosis of bleeding esophageal varices.

Authors:  T Prindiville; W Trudeau
Journal:  Gastrointest Endosc       Date:  1986-12       Impact factor: 9.427

8.  Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial.

Authors:  D Westaby; B R Macdougall; R Williams
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

9.  Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices.

Authors:  M S Barsoum; F I Bolous; A A El-Rooby; M A Rizk-Allah; A S Ibrahim
Journal:  Br J Surg       Date:  1982-02       Impact factor: 6.939

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  4 in total

1.  Transabdominal gastro-esophageal devascularization and esophageal transection for bleeding esophageal varices after failed injection sclerotherapy: long-term follow-up report.

Authors:  Shabir Ahmad Qazi; Kamran Khalid; Abdul Majeed Abdul Hameed; Khalid Al-Wahabi; Radwan Galul; Saleh M Al-Salamah
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Improved results with selective distal splenorenal shunt in a highly selected patient population. A prospective study.

Authors:  K J Paquet; M A Mercado; P Koussouris; J F Kalk; F Siemens; F Cuan-Orozco
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

3.  Long-term endoscopic injection sclerotherapy of bleeding esophageal varices. A prospective analysis of results by endoscopy, manometry and 24-h pH-monitoring.

Authors:  F Siemens; K J Paquet; P Koussouris; M A Mercado; J F Kalk
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

Review 4.  The surgeon's role in the management of portal hypertension.

Authors:  J Terblanche
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.